Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $99000.0.

  • Nephros' Cash from Operations rose 11589.09% to $99000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 23102.95%. This contributed to the annual value of -$500000.0 for FY2024, which is 16045.95% down from last year.
  • Per Nephros' latest filing, its Cash from Operations stood at $99000.0 for Q3 2025, which was up 11589.09% from $994000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Cash from Operations ranged from a high of $1.3 million in Q4 2024 and a low of -$1.8 million during Q1 2022
  • Over the past 5 years, Nephros' median Cash from Operations value was -$170000.0 (recorded in 2022), while the average stood at -$153105.3.
  • Its Cash from Operations has fluctuated over the past 5 years, first crashed by 316727.27% in 2022, then skyrocketed by 57472.53% in 2024.
  • Over the past 5 years, Nephros' Cash from Operations (Quarter) stood at -$335000.0 in 2021, then skyrocketed by 41.79% to -$195000.0 in 2022, then tumbled by 40.0% to -$273000.0 in 2023, then soared by 574.73% to $1.3 million in 2024, then plummeted by 92.36% to $99000.0 in 2025.
  • Its last three reported values are $99000.0 in Q3 2025, $994000.0 for Q2 2025, and $322000.0 during Q1 2025.